WILMINGTON, N.C., April 15, 2008 (PRIME NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release first quarter 2008 financial results after market close on Thursday, May 1, 2008. Rick Randall, President and Chief Executive Officer of TranS1, and Mike Luetkemeyer, Chief Financial Officer, will host a conference call starting at 4:30 p.m. EDT on the same day. The call will be concurrently webcast.
To listen to the conference call on your telephone, please dial 877-397-0300 for domestic callers and 719-325-4897 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the TranS1 Web site at http://www.trans1.com under the investor relations section.
Schedule this webcast into MS-Outlook calendar (click open when prompted):http://apps.shareholder.com/PNWOutlook/t.aspx?m=30878&k=4AB31808
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products -- the AxiaLIF(r) and the AxiaLIF 360:o(tm) in the U.S. and Europe. In addition the company currently markets a two-level fusion product -- the AxiaLIF 2L(tm) in Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit http://www.trans1.com.